TMCnet News
Powerhouse Life Sciences Team Joins GoodwinGlobal 50 law firm Goodwin announced today that a team of four partners will join its premier Life Sciences practice. Graham Defries and Andrew Harrow will join Goodwin's London office and formally establish the firm's European Life Sciences practice. Kristopher Brown and Jonathan Schur will join the New York office and expand the firm's award-winning national practice. All four will start at Goodwin upon completion of their notice period. "Graham, Kristopher, Jonathan, and Andrew make up a truly unique, cross-border team that represents the life sciences industry's key players - from emerging and later stage biotechnology and pharmaceutical companies across their full life cycles, to boards and venture firms across all of their dealmaking needs - on both continents," said Mitchell Bloom, Chair of Goodwin's Life Sciences practice. "The type of deals they focus on, their networks, a loyal client following, and industry expertise make this team a perfect fit for our growing life sciences platform and significantly expand our cross-border capabilities. We are thrilled that Graham, Kristopher, Jonathan, and Andrew have chosen to join the Goodwin partnership."
"This is a unique opportunity, together with some of my longstanding colleagues in London and the U.S., to launch the European life sciences practice of the gold standard life sciences law firm in the U.S.," said Defries. "I am excited to be joining the preeminent global team at Goodwin to help develop the firm's transactional European life sciences practice, and to continue to work with private equity sponsor clients on M&A transactions." "With our long history of collaborating with our colleagues in London, and Goodwin's deep U.S. expertise and resources, we are thrilled to offer global life sciences and technology clients the complete suite of legal services they require," said Brown. Goodwin's Life Sciences practice was named "Practice Group of the Year" for the past two years by Law360, which called Goodwin "a top choice for high-profile pharmaceutical clients, particularly in licensing deals, mergers and acquisitions, and initial public offerings." Goodwin has been recognized by U.S. News and World Report - Best Lawyers as "Biotech Firm of Year" for five out of last six years. In addition, the firm was named "2017 IP Law Firm of the Year" by LMG Life Sciences.
About Goodwin View source version on businesswire.com: https://www.businesswire.com/news/home/20180416005877/en/ |